Clinical Trial

PEEP in Patients With Acute Respiratory Failure

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Positive end-expiratory pressure (PEEP) has become an essential component of the care of critically ill patients who require ventilatory support. In 1975, several investigators published the effects of PEEP in 15 mechanically ventilated patients with acute respiratory failure (ARF) supported by mechanical ventilation. FiO2 ranged between 21% to 75% and the tidal volume between 13 to 15 mL/kg. PEEP was increased in 3 cmH2O steps until cardiac output fell. The aim was to identify the "optimum" PEEP level. "Best" PEEP was associated simultaneously with the best static compliance of the respiratory system, the greatest oxygen transport, and the lowest dead space fraction. That study established the basis for the use of PEEP in patients with ARF worldwide. Although currently patients with ARF are ventilated with much lower tidal volumes, that study has never been validated. It is unknow whether their findings are currently valid, generalizable, and reproducible.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-05-31; most recent amendment 2025-04-16.
Status change: Not Yet Recruiting → Recruiting 2022-03-22
Trial Details
NCT Number NCT04912960
Lead Sponsor Jesus Villar
Conditions Acute Respiratory Failure With Hypoxia
Enrollment 15 participants
Start Date 2021-06-10
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-20